Laura D'Erasmo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia	JAMA CARDIOLOGY	2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2024
Is bempedoic acid a drug for female subjects? Preliminary analysis in an Italian cohort	ATHEROSCLEROSIS	2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment	STAR PROTOCOLS	2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice?	CURRENT ATHEROSCLEROSIS REPORTS	2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.	LIVER INTERNATIONAL	2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study	LA RADIOLOGIA MEDICA	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2022
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study	THE LANCET	2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease	BIOMEDICINES	2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway	BIOMOLECULES	2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content	ATHEROSCLEROSIS	2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study	FRONTIERS IN GENETICS	2022
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification	ATHEROSCLEROSIS	2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis	BIOCHIMICA AND BIOPHYSICA ACTA. MOLECULAR AND CELL BIOLOGY OF LIPIDS	2022

Progetti di Ricerca

Studio multicentrico osservazionale di valutazione dell'efficacia della terapia con lomitapide nel migliorare il profilo lipidico e ridurre l'incidenza di eventi cardiovascolari in pazienti affetti da ipercolesterolemia familiare omozigote: analisi ...